Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CDKN2A variants in a population-based sample of Queensland families with melanoma.

Journal of the National Cancer Institute - 3 Mar 1999

Aitken J, Welch J, Duffy D, Milligan A, Green A, Martin N, Hayward N

Abstract excerpt

BACKGROUND: Mutations in the CDKN2A gene confer susceptibility to cutaneous malignant melanoma (CMM); however, the population incidence of such mutations is unknown. Polymorphisms in CDKN2A have also been described, but it is not known whether they influence melanoma risk. We investigated the association of CDKN2A mutations and polymorphisms with melanoma risk in a population-based sample of families ascertained...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoradiography
Share to Cyclin-Dependent Kinase Inhibitor p16

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cyclin-Dependent Kinases

Share to Melanoma

Share to Polymorphism, Single-Stranded Conformational

Share to Queensland

Share to Skin Neoplasms

Source

Identifiers

PMID: 10070944
DOI: 10.1093/jnci/91.5.446

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CDKN2A variants in a population-based sample of Queensland families with melanoma.PMID 10070944Read ↗

Prevalence of Germline BAP1, CDKN2A, and CDK4 Mutations in an Australian Population-Based Sample of Cutaneous Melanoma Cases.Semantic proximity Read ↗

Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.Semantic proximity Read ↗

Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents.Semantic proximity Read ↗

Phenocopies in melanoma-prone families with germ-line CDKN2A mutations.Semantic proximity Read ↗

The Queensland Study of Melanoma: environmental and genetic associations (Q-MEGA); study design, baseline characteristics, and repeatability of phenotype and sun exposure measures.Semantic proximity Read ↗

Population-based prevalence of CDKN2A and CDK4 mutations in patients with multiple primary melanomas.Semantic proximity Read ↗

Population-based prevalence of CDKN2A mutations in Utah melanoma families.Semantic proximity Read ↗

Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma.Semantic proximity Read ↗

Melanoma risk for CDKN2A mutation carriers who are relatives of population-based case carriers in Australia and the UK.Semantic proximity Read ↗

Familial melanoma: a meta-analysis and estimates of attributable fraction.Semantic proximity Read ↗

Analysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindreds.Semantic proximity Read ↗

CDKN2A mutations in melanoma families from Uruguay.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.